药物化学当前主题 SCIE

期刊简介预计审稿时间： 一般,3-8周

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

《药物化学最新主题》是药物化学家和其他相关学科人员热切关注的领域评论论坛。每期专门讨论一个特定主题，包含六到九篇评论，为读者提供该领域的全面概述。每期都将由一位客座编辑负责编辑，他是所评论主题的专家。《药物化学最新主题》的范围将涵盖药物化学的所有领域，包括合理药物设计、合成化学、生物有机化学、高通量筛选、组合化学、化合物多样性测量、药物吸收、药物分布、代谢、新兴药物靶点、天然产物、药物基因组学和结构-活性关系的最新发展。药物化学是一门快速成熟的学科。研究结构和功能之间的关系对于理解生命的分子基础至关重要。 《药物化学最新主题》旨在促进科学知识和洞察力的增长，并促进发现和开发用于治疗人类衰弱性疾病的新治疗剂。对于希望随时了解最新和最重要进展的药物化学家来说，这本期刊是必不可少的。

《Current Topics In Medicinal Chemistry》(药物化学当前主题)编辑部通讯方式为BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。